Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

538
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
538
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

443
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
443

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

K-Ras controls asymmetric cell divisions from the primary cilium.

Cell death & disease·2026
Same author

The role of PDE6D in trafficking KRAS.

Biological chemistry·2026
Same author

Cooperative Binding Domains Enhance Sensitivity and Overcome the Hook Effect in Two-Component Protein Biosensors.

ACS sensors·2026
Same author

KRAS Can Bind to FTase Despite Disruption of the CAAX Binding Site.

Biochemistry·2026
Same author

The impact of RAS on cell differentiation in health and disease.

The Biochemical journal·2025
Same author

The PP2A-B55α phosphatase is a master regulator of mitochondrial degradation and biogenesis.

Science advances·2025

相关实验视频

Updated: Jan 11, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.8K

开发一种基因编码和强大的PDE6D抑制剂.

Atanasio Gómez-Mulas1, Elisabeth Schaffner-Reckinger1, Hanne Peeters2

  • 1Cancer Cell Biology and Drug Discovery Group, Department of Life Sciences and Medicine, University of Luxembourg, 2 place de l'Université, 4365, Esch-sur-Alzette, Luxembourg.

Chembiochem : a European journal of chemical biology
|November 18, 2025
PubMed
概括

研究人员开发了基因编码的PDE6D抑制剂,如SNAP-STI,灵感来自自然货物. 这些新型抑制剂显示出比小分子更高的功效,但不能有效地阻止K-Ras信号传递,这表明PDE6D不是理想的癌症标.

关键词:
在PDE6D中,它是PDE6D.拉斯拉斯拉斯拉斯拉斯拉斯拉斯拉斯拉斯拉索病症是一种RAS病症.癌症 癌症 癌症 癌症 癌症抑制剂 抑制剂 抑制剂

更多相关视频

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness
06:21

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness

Published on: May 7, 2018

6.9K
Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.4K

相关实验视频

Last Updated: Jan 11, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.8K
An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness
06:21

An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness

Published on: May 7, 2018

6.9K
Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.4K

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 基化酶6D (PDE6D) 是前化蛋白的伴侣,包括致癌性K-Ras.
  • 小分子抑制剂的PDE6D面临的挑战是水溶性差.
  • 开发有效的抑制剂对于理解PDE6D在癌症等疾病中的作用至关重要.

研究的目的:

  • 开发基因编码的PDE6D抑制剂,以自然高亲和力货物为灵感.
  • 为了比较这些新型抑制剂与现有的小分子抑制剂的功效.
  • 评估PDE6D抑制对K-Ras膜定和下游信号的有效性.

主要方法:

  • 基于PDE6D自然载荷的基因编码抑制剂的设计和合成.
  • 在体外测试以评估PDE6D结合抑制.
  • 基于细胞的测试来测量K-Ras膜定和MAPK信号传递.
  • 新型抑制剂与已确定的小分子抑制剂的比较.

主要成果:

  • 基因编码的抑制剂SNAP-STI,一种法尼西化四,对PDE6D有很高的亲和力.
  • 与小分子抑制剂相比,SNAP-STI在阻断法尼西拉载荷结合方面表现出更大的功效.
  • 通过SNAP-STI抑制K-Ras膜定和MAPK信号传递是最小的,与PDE6D敲击效应保持一致.

结论:

  • 基因编码的抑制剂为向PDE6D提供了有效的策略.
  • 对于有效的K-Ras膜定和MAPK抑制,PDE6D不是一个合适的替代标.
  • 这项研究为设计用于生物研究和目标验证的高亲和度PDE6D抑制剂建立了可通用的方法.